Discover open access scientific publications

Search, annotate, share and cite publications

Publications by C. Freiburghaus

Bortezomib Prevents Development of Cytarabine Resistance in a Mantle Cell Lymphoma in Vitro Model

Hematological Oncology

English

The Immune Microenvironment as a Prognostic Tool for MCL Patients

Hematological Oncology

English

Related publications

Bortezomib Maintenance After R-Chop, Cytarabine and Autologous Stem Cell Transplantation in Newly Diagnosed Patients With Mantle Cell Lymphoma, Results of a Randomised Phase II HOVON Trial

British Journal of Haematology

Hematology

2020

English

Sorafenib Inhibits Cell Migration and Stroma-Mediated Bortezomib Resistance by Interfering B-Cell Receptor Signaling and Protein Translation in Mantle Cell Lymphoma

Clinical Cancer Research

Cancer Research

Oncology

2012

English

Bortezomib-Resistant Nuclear Factor κB Expression in Stem-Like Cells in Mantle Cell Lymphoma

Experimental Hematology

English

The Hsp90 Inhibitor IPI-504 Overcomes Bortezomib Resistance in Mantle Cell Lymphoma in Vitro and in Vivo by Down-Regulation of the Prosurvival ER Chaperone BiP/Grp78

English

Multicenter Phase II Study of Bortezomib in Patients With Relapsed or Refractory Mantle Cell Lymphoma

Journal of Clinical Oncology

English

Efficacy of Subcutaneous Bortezomib in the Management of Patients With Multiple Myeloma or Relapsed Mantle Cell Lymphoma

Clinical Medicine Insights: Therapeutics

Medicine

Pharmacology

Pharmaceutical Science

2014

English

Combined Administration of Rituximab and ON 013105 Induces Apoptosis in Mantle Cell Lymphoma Cells and Reduces Tumor Burden in a Mouse Model of Mantle Cell Lymphoma

Clinical Cancer Research

Cancer Research

Oncology

2012

English

Phase 2 Trial of Rituximab and Bortezomib in Patients With Relapsed or Refractory Mantle Cell and Follicular Lymphoma

English

Novel Targeted Strategies to Overcome Microenvironment-Dependent Resistance in Mantle Cell Lymphoma

Hematological Oncology

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by C. Freiburghaus

Bortezomib Prevents Development of Cytarabine Resistance in a Mantle Cell Lymphoma in Vitro Model

The Immune Microenvironment as a Prognostic Tool for MCL Patients

Related publications

Bortezomib Maintenance After R-Chop, Cytarabine and Autologous Stem Cell Transplantation in Newly Diagnosed Patients With Mantle Cell Lymphoma, Results of a Randomised Phase II HOVON Trial

Sorafenib Inhibits Cell Migration and Stroma-Mediated Bortezomib Resistance by Interfering B-Cell Receptor Signaling and Protein Translation in Mantle Cell Lymphoma

Bortezomib-Resistant Nuclear Factor κB Expression in Stem-Like Cells in Mantle Cell Lymphoma

The Hsp90 Inhibitor IPI-504 Overcomes Bortezomib Resistance in Mantle Cell Lymphoma in Vitro and in Vivo by Down-Regulation of the Prosurvival ER Chaperone BiP/Grp78

Multicenter Phase II Study of Bortezomib in Patients With Relapsed or Refractory Mantle Cell Lymphoma

Efficacy of Subcutaneous Bortezomib in the Management of Patients With Multiple Myeloma or Relapsed Mantle Cell Lymphoma

Combined Administration of Rituximab and ON 013105 Induces Apoptosis in Mantle Cell Lymphoma Cells and Reduces Tumor Burden in a Mouse Model of Mantle Cell Lymphoma

Phase 2 Trial of Rituximab and Bortezomib in Patients With Relapsed or Refractory Mantle Cell and Follicular Lymphoma

Novel Targeted Strategies to Overcome Microenvironment-Dependent Resistance in Mantle Cell Lymphoma